![Kristina Torfgård](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristina Torfgård
Chief Executive Officer at
IRLAB THERAPEUTICS AB
Profile
Kristina Torfgård is currently Chief Executive Officer at IRLAB Therapeutics AB since 2024.
Formerly, Chief Executive Officer at Alzinova AB from 2019 to 2024.
Principal at AstraZeneca AB. Vice President-Clinical & Regulatory Affairs at Albireo Ltd. VP-Clinical, Regulatory Affairs & Global Project at Albireo AB from 2014 to 2017.
Vice President-Clinical & Regulatory Affairs at Albireo Pharma, Inc. from 2017 to 2019.
Education includes a doctorate from the University of Linköping.
Kristina Torfgård active positions
| Companies | Position | Start |
|---|---|---|
| IRLAB THERAPEUTICS AB | Chief Executive Officer | 31/07/2024 |
Former positions of Kristina Torfgård
| Companies | Position | End |
|---|---|---|
| ALZINOVA AB | Chief Executive Officer | 30/07/2024 |
| ALBIREO PHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | General Counsel | 31/01/2017 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | General Counsel | - |
Training of Kristina Torfgård
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
IRLAB Therapeutics AB
 IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
- Stock Market
- Insiders
- Kristina Torfgård
